Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × Clofarabine × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 25 INDUSTRY 6 NIH 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoproliferative Disorders 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1

Interventions

sargramostim 1 pembrolizumab 1 Injections 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cryotherapy 1 Cryosurgery 1 Clofarabine 1 Celecoxib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00028418 2015-03-25

Clofarabine in Chronic Lymphocytic Leukemia

FDA Office of Orphan Products Development

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡